Professor Thomas Walther receives funding from Enterprise Ireland under the TTSI3 Pipeline Fund

15 Jul 2020

Congratulations to Professor Thomas Walther, the Head of Department for Pharmacology and Therapeutics, who submitted an application to Enterprise Ireland for TTSI3 Pipeline Fund support and has subsequently been awarded funding for his project, entitled:  “Modelling modifications to small molecule drug candidates for use in restoring lung barrier function in acute respiratory distress syndrome (ARDS) patients infected with COVID-19.”

Professor Walther said, "this funding will significantly help us with developing a new drug for the treatment of acute lung failure in COVID-19, the main cause of death in these patients.”

Department of Pharmacology and Therapeutics

Cógaseolaíocht agus Teiripic

Room 2.36B, 2nd floor floor, T12XF62